MedPath

A Clinical Study on the Improvement of Skin and Living Conditions After Drinking Rosa Roxburghii and Pomegranate Drinks

Not Applicable
Completed
Conditions
Skin Laxity
Interventions
Combination Product: skin care product
Other: Drinks with active ingredients Rosa Roxburghii and Pomegranate
Registration Number
NCT06274450
Lead Sponsor
Botanee Group Co., Ltd.
Brief Summary

The main objective of the study is to observe changes in the subjects' skin condition and life status after 8 weeks of drinking rosa roxburghii and pomegranate drinks.

This is a single-center, randomized, single-blind, controlled, 8-week (56-day) clinical study conducted in Chinese healthy women aged 25-45 years old who were offered a rosa roxburghii and pomegranate drink.

Detailed Description

The study population is 70 healthy Chinese women aged 25-45 years who report current problems with dryness, roughness, dullness, and lack of elasticity on their face. The subjects will be randomly divided into an experimental group and a control product group of 35 subjects each.

Subjects will be formally enrolled after site assessment and subsequent site visits and test product administration. During the test cycle, subjects in the test group will take Prickly Pear Pomegranate Drink with active ingredients for 8 weeks, while the control product group will not take any test product. In order to avoid the influence of different skincare products on the results, all subjects will be asked to use a basic skincare product with moisturising ingredients only, provided by the sponsor, for the duration of the test. The efficacy of the test products will be verified by comparing the changes in skin condition and lifestyle of the subjects in the experimental group before taking the test products and 4 weeks and 8 weeks after taking the test products, as well as by comparing the differences in skin condition and lifestyle between the experimental group and the control group.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
70
Inclusion Criteria
  1. 25-45 years old, Chinese female;
  2. The subject's self-reported facial problems such as dryness, roughness, dullness, and lack of elasticity;
  3. The subject's BMI is between 18~24kg/m2;
  4. After the doctor's clinical evaluation, there is at least one obvious pigmentation spot with an ITA° difference of more than 10° on the face and the surrounding adjacent skin, and the diameter is not less than 3mm (it cannot be freckles, pigmented nevi, etc. that are difficult to improve clinically using topical preparations);
  5. Corneometer base measurement of facial skin moisture at 15~45 (Corneometer Unit, C.U.) Between;
  6. Be in good health and free of any other chronic diseases other than skin problems or diseases being treated;
  7. Voluntarily participate in the test and sign the informed consent form;
  8. Willing to comply with all evaluation requirements;
Exclusion Criteria
  1. Those who have used products, health foods or drugs with antioxidant and anti-aging effects in the past 2 months;
  2. Those who have used any products, health foods or drugs (such as hydroquinone preparations) that affect skin color in the past 2 months;
  3. Those who have used tretinoin preparations or undergone medical aesthetic treatments such as chemical peels, lasers, and pulsed light at the test site in the past 3 months;
  4. Those who are inevitably exposed to long-term sunlight;
  5. Intending to become pregnant, or being pregnant or breastfeeding;
  6. Have a history of alcoholism;
  7. Have a history of allergies;
  8. Participated in any clinical trial evaluation within 1 month;
  9. Those who have applied any anti-inflammatory drugs to the test site within the past two months;
  10. Those who have suffered from skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.);
  11. patients with insulin-dependent diabetes;
  12. Patients with asthma or other chronic respiratory diseases who are being treated;
  13. Have taken/injected anti-allergic drugs in the past 1 month;
  14. Patients who have received anti-cancer chemotherapy or immunotherapy patients within the past 6 months;
  15. Have a serious internal medicine disease, have any other health problems or chronic diseases;
  16. Coated with retinoids, A hydroxy acids, salicylic acids, hydroquinone within the past 3 months, or prescription drugs (antibiotics, retinoids, A hydroxy acids and steroids) in use within the past 6 months, oral contraceptives (if you have been taking the same contraceptive pills for the past 6 months, you can continue to take them);
  17. Experts or professionals believe that there are other iatrogenic causes that affect the results of the review.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Drinks with active ingredients Rosa Roxburghii and Pomegranateskin care productTake drinks with active ingredients such as Rosa Roxburghii and Pomegranate. Drink every morning on an empty stomach, 20ml/2 sachets/day.
Blank Groupskin care productNot taking drinks
Drinks with active ingredients Rosa Roxburghii and PomegranateDrinks with active ingredients Rosa Roxburghii and PomegranateTake drinks with active ingredients such as Rosa Roxburghii and Pomegranate. Drink every morning on an empty stomach, 20ml/2 sachets/day.
Primary Outcome Measures
NameTimeMethod
Changes in the proportion of crow's feet areaWeek0(Baseline)、Week4、Week8

Calculate the proportion of crow's feet area by Visia CR images.

Skin condition Assessment after 8-week applicationWeek8

Obtain data on agreement with skin condition improvement by skin condition self-assessment questionnaire. The questionnaire is a 9-point scale, with 1 indicating strong disagreement and 9 indicating strong agreement.

Changes in the skin firmnessWeek0(Baseline)、Week4、Week8

Obtain change of skin firmness by cutometer.

Changes in the melanin contentWeek0(Baseline)、Week4、Week8

Obtain change of melanin content by Mexameter MX18.

Changes in the skin hydrationWeek0(Baseline)、Week4、Week8

Obtain change of skin hydration by Corneometer.

Changes in the individual type angleWeek0(Baseline)、Week4、Week8

Obtain change of Individual type angle by Colorimeter.

Changes in the proportion of fine lines under the eyeWeek0(Baseline)、Week4、Week8

Calculate the proportion of fine lines under the eye by Visia CR images.

Changes in the skin glossinessWeek0(Baseline)、Week4、Week8

Obtain change of skin glossiness by Glossymeter.

Changes in the skin elasticityWeek0(Baseline)、Week4、Week8

Obtain change of skin elasticity by cutometer.

Changes in the CIE RGB of skin toneWeek0(Baseline)、Week4、Week8

Dermatologist use PANTONE SkinTone (Pantone color card) skin color guide to evaluate skin tone grade of subjects. Find the CIE RGB corresponding to the skin tone grade in Pantone ColorManager software and convert it into a color value using the formula for data analysis: CIE RGB = R+G\*256+B\*256\*256.

Calculate the change of CIE RGB of skin tone.

Changes in the grade of PigmentationWeek0(Baseline)、Week4、Week8

Obtain change of degree of Pigmentation severity by Dermatologist evaluation according to Skin Aging ATLAS of Asian Type.

Skin condition Assessment after 4-week applicationWeek4

Obtain data on agreement with skin condition improvement by skin condition self-assessment questionnaire. The questionnaire is a 9-point scale, with 1 indicating strong disagreement and 9 indicating strong agreement.

Secondary Outcome Measures
NameTimeMethod
Changes in the satisfaction with the quality of lifeWeek0(Baseline)、Week4、Week8

Obtain change of satisfaction with the quality of life accessed by WHOQOL-100 questionnaire. The questionnaire is a 5-point scale, with 1 indicating very dissatisfied and 5 indicating very satisfied.

Trial Locations

Locations (1)

Shanghai China-norm Quality Technical Service Co ,Ltd

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath